Back to results
US 7,803,824 B2Granted
Use of inhibitors of Jun N-terminal kinases to treat glaucoma
AssigneeAlcon Inc.
InventorsDebra L. Fleenor, Iok-Hou Pang
Life of this patent
Estimating the term…
Abstract
Compositions and methods for lowering IOP and/or providing neuroprotection are disclosed. The compositions and methods are particularly directed to the use inhibitors of Jun N-terminal kinases (JNK) to lower IOP and/or provide neuroprotection.
Claims3
A method for decreasing ocular hypertension, which comprises administering to a human patient identified as having glaucoma a composition comprising an effective amount of a JNK inhibitor and a pharmaceutically acceptable vehicle, wherein the JNK inhibitor is
Dependencies are inferred from the claim text.